Chaired by globally renowned nuclear medicine expert Prof. Ken Herrmann, M.D. Other Board members James Cook, Jason Lewis, Ph.D., and Michael ...
In today’s Pharmaceutical Executive Daily, the FDA introduces a new superiority standard for future CAR-T approvals, Relation ...
Three-quarters of those surveyed said the program’s resources helped reduce unwanted physical side effects, and more than 80% said it lessened at least one aspect of financial stress. Overall, 85% ...
Oppenheimer upgraded Dyne Therapeutics (DYN) on Wednesday, citing a positive read-through from data that Novartis’ (NVS) buyout target Avidity Biosciences (RNA) is set to release this year from a late ...
On 9 December 2025, Relation Therapeutics announced a multi-program collaboration with Novartis, securing US$55 million in ...
Dec 10 (Reuters) - Pfizer will cut over 200 jobs in Switzerland as part of its multi-year cost reduction program, ...
The agency gave the green light to a U.S. company manufacturing Augmentin XR, an antibiotic first approved more than two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results